Predictive Value of Histopathological Variables and Peripheral Immune-Inflammatory Markers in De Novo Metastatic Breast Cancer: Development and Clinical Utility of the Novel KiTNASP Score.

Yilmaz S, Yur M, Aygen E, İlhan YS, Akbaş A, Balin ŞÖ, Avul AR

Open source

DOI
10.3390/biomedicines14091960
Published
2026 Aug 31
Container
Biomedicines
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14091960,
  title = {Predictive Value of Histopathological Variables and Peripheral Immune-Inflammatory Markers in De Novo Metastatic Breast Cancer: Development and Clinical Utility of the Novel KiTNASP Score.},
  author = {Yilmaz S and Yur M and Aygen E and İlhan YS and Akbaş A and Balin ŞÖ and Avul AR},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14091960},
  url = {https://doi.org/10.3390/biomedicines14091960}
}

RIS

TY  - JOUR
TI  - Predictive Value of Histopathological Variables and Peripheral Immune-Inflammatory Markers in De Novo Metastatic Breast Cancer: Development and Clinical Utility of the Novel KiTNASP Score.
AU  - Yilmaz S
AU  - Yur M
AU  - Aygen E
AU  - İlhan YS
AU  - Akbaş A
AU  - Balin ŞÖ
AU  - Avul AR
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14091960
UR  - https://doi.org/10.3390/biomedicines14091960
ER  - 

APA

S, Y., M, Y., E, A., YS, İ., A, A., ŞÖ, B., & AR, A. (2026). Predictive Value of Histopathological Variables and Peripheral Immune-Inflammatory Markers in De Novo Metastatic Breast Cancer: Development and Clinical Utility of the Novel KiTNASP Score.. Biomedicines. https://doi.org/10.3390/biomedicines14091960

Source records